Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Washington Cancer Institute at Washington Hospital Center
Washington D.C., District of Columbia, United States
- Mbccop - Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Central Georgia Gynecologic Oncology
Macon, Georgia, United States
- Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Women'S Cancer Center - Lake Mead
Las Vegas, Nevada, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Presbyterian Cancer Center at Presbyterian Hospital
Charlotte, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Metrohealth Cancer Care Center at Metrohealth Medical Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
- Lake/university Ireland Cancer Center
Mentor, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital
Abington, Pennsylvania, United States
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- 31 Jan 2012
- Completion
- —
- Last update posted
- 12 Dec 2017
- Registered enrollment
- 20
- Registry id
- NCT00379145
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.